Mohamad-Reza Aghanoori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohamad-Reza Aghanoori has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- A. Micheil Innes
Departments of Medical Genetics and Pediatrics and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada
1 shared publication Alexia Bourgois
Service de Génétique, Centre Hospitalier Universitaire de Caen
1 shared publicationAngie Lichty
Greenwood Genetic Center
1 shared publication- Antonio Vitobello
INSERM, CTM UMR1231, équipe GAD, FHU TRANSLAD, Laboratoire de Génomique Médicale Université Bourgogne Europe, CHU Dijon Bourgogne Dijon France
1 shared publication Boris Keren
Department of Genetics, La Pitié-Salpêtrière Hospital, Assistance Publique Hospital of Paris
1 shared publicationBrooke Rackel
Department of Medical Genetics, Cumming School of Medicine, University of Calgary
1 shared publication
Latest Publications
- Open Access
Genetic variants disrupting activity-dependent CELF2 shuttling cause neuronal hyperexcitability, learning deficits, and seizures
De novo heterozygous variants in the CELF2 gene have recently been associated with a rare neurodevelopmental disorder. However, the mechanisms linking specific variants to distinct clinical phenotypes remain poorly understood. Here, we report a new cohort of 14 individuals with de novo CELF2 variants, providing evidence that variants causing CELF2 cytoplasmic mislocalization, but not its loss-of-function, are associated with seizures. Using proband induced pluripotent stem cell-derived neurons and transgenic mouse models, we show that CELF2 undergoes activity-dependent nucleocytoplasmic shuttling in excitatory neurons, and its cytoplasmic retention causes neuronal hyperexcitability, leading to learning and memory deficits. In the cytoplasm, CELF2 regulates mRNAs critical for synaptic functions and neuronal excitability implicated in epileptic seizures and intellectual disability. Through drug screening, we identify AKT signaling as a key regulator of CELF2 shuttling and a target for treating CELF2-associated hyperexcitability. Our findings expand the clinical and genetic spectrum of CELF2-related neurodevelopmental disorders and reveal variant-specific mechanisms that link CELF2 mislocalization to neuronal hyperexcitability, learning deficits, and epileptic seizures. One Sentence Summary: CELF2 variants link protein mislocalization to neuronal hyperexcitability, learning deficits, and epileptic seizures.
Open AccessGenetic variants disrupting activity-dependent CELF2 shuttling cause neuronal hyperexcitability, learning deficits, and seizures
De novo heterozygous variants in the CELF2 gene have recently been associated with a rare neurodevelopmental disorder. However, the mechanisms linking specific variants to distinct clinical phenotypes remain poorly understood. Here, we report a new cohort of 14 individuals with de novo CELF2 variants, providing evidence that variants causing CELF2 cytoplasmic mislocalization, but not its loss-of-function, are associated with seizures. Using proband induced pluripotent stem cell-derived neurons and transgenic mouse models, we show that CELF2 undergoes activity-dependent nucleocytoplasmic shuttling in excitatory neurons, and its cytoplasmic retention causes neuronal hyperexcitability, leading to learning and memory deficits. In the cytoplasm, CELF2 regulates mRNAs critical for synaptic functions and neuronal excitability implicated in epileptic seizures and intellectual disability. Through drug screening, we identify AKT signaling as a key regulator of CELF2 shuttling and a target for treating CELF2-associated hyperexcitability. Our findings expand the clinical and genetic spectrum of CELF2-related neurodevelopmental disorders and reveal variant-specific mechanisms that link CELF2 mislocalization to neuronal hyperexcitability, learning deficits, and epileptic seizures. One Sentence Summary: CELF2 variants link protein mislocalization to neuronal hyperexcitability, learning deficits, and epileptic seizures.
- 27 May 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (7) , 167925
AI-assisted multi-OMICS analysis reveals new markers for the prediction of AD
- 27 May 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (7) , 167925
AI-assisted multi-OMICS analysis reveals new markers for the prediction of AD